Topvision Eye Specialist Berhad Launches IPO, Subscription Opens on 25th November 2024
HC Wainwright & Co. Reiterates Buy on Alpha Tau Medical, Maintains $9 Price Target
Alpha Tau Medical Analyst Ratings
Korro Bio Has Received Approval From The Australian Bellberry Human Research Ethics Committee And Clearance From The Australian Therapeutic Goods Administration To Initiate A Phase 1/2a Study Of KRRO-110 For Alpha-1 Antitrypsin Deficiency
Barclays Upgrades Bank of Nova Scotia to Equal-Weight, Raises Price Target to C$81
Metro Inc. (MTRAF) Q4 2024 Earnings Call Transcript Summary